By 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. Our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, led this research, which was presented at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. These projections, prepared in collaboration with MD Anderson Cancer Center… Read more »
Around the world, physicians are seeking better treatments for COVID-19. What can they learn from cancer research? Today, STAT published an article written by Cancer Commons founder Marty Tenenbaum, PhD, in which he outlines how our strategy to learn from cancer patients who are trying treatments beyond the standard of care could also be applied to the coronavirus pandemic: “This same rapid-learning approach can… Read more »
Erika Vial Monteverdi, Executive Director of Cancer Commons
Cancer Commons is a patient-centric, nonprofit network of patients, physicians, and scientists that helps identify the best options for treating an individual’s cancer. Here, our Curious Dr. George asks executive director Erika Vial Monteverdi what sets Cancer Commons apart. Q: As the Executive Director of Cancer Commons, how do you consider our approach to be uniquely different from that of many other organizations working… Read more »
Lola Rahib, PhD (left), and Conan Kinsey, MD, PhD (right), present our findings in San Diego, CA
Today, our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, presented initial findings from our real-world data registry on a novel treatment combination for pancreatic cancer patients. Performed in collaboration with xCures and the University of Utah’s Huntsman Cancer Institute, this research was presented at the Special Conference on Advancing Precision Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies, hosted… Read more »
In a new Q&A with the Precision Medicine World Conference, Executive Director Erika Vial Monteverdi outlines how Cancer Commons is helping people navigate their treatment, and shares her vision for the future: “We are trying to help advanced cancer patients get practical ‘shots on goal’ against their cancer AND learn from the massive number of therapies tried with patients.” Click here for the full Q&A.… Read more »
Cancer Commons has partnered with the Precision Medicine World Conference to organize a dedicated Patient Track at their meeting in Silicon Valley, CA, in January 2020. We’ve lined up a great group of people to speak on a variety of topics about putting patient needs first, and understanding and accessing the latest cancer treatment options. Patients, caregivers, and advocates are welcome to attend, and can… Read more »
Last week, Cancer Commons founder Marty Tenenbaum, PhD, shared our mission and impact at a fundraiser gala hosted by the Kids & Art Foundation in Palo Alto, CA. The theme of the night? “Technology. Research. Therapy. Conversations on improving quality of cancer care.” Marty, who founded Cancer Commons after his own cancer journey, joined other innovative leaders at the gala to discuss the hopeful progress being… Read more »
In this month’s issue of Gentry Magazine, executive director Erika Vial Monteverdi shares the incredible impact that Cancer Commons has had for patients, as well as our bold and unique vision for the future: “At the core, it’s a very simple idea: namely, to wrap research and care around patient needs first. This starts with understanding a patient’s diagnosis, giving them compassion through good… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will speak about Cancer Commons at the Stanford Medicine X | CHANGE conference this Sunday, September 22 at 9:15 am. The conference is a “premier gathering of patients, providers, researchers, designers and technologists who are leading disruptive CHANGE in health care.” Marty, who founded Cancer Commons after his own cancer journey, will discuss some of the major problems he’s working to fix: Clinical oncology… Read more »
H8Cancer Founder and CEO Simeon Jaggernauth, DO, FACP
On Saturday, Sandy Noack, Cancer Commons development officer and patient concierge, joined nearly 2,000 guests to “rock for a cure” at Tomstock 2019. This annual, invitation-only event raises funds for the H8 Cancer Foundation, a major supporter of our mission and work. Although our founder Marty Tenenbaum was unable to attend, he delivered this heartfelt message, read to the crowd by Tomstock host Carman Duvall:… Read more »
